Cytocybernetics has developed novel technology to improve drug safety screening. It will ensure that new drugs brought to market do not cause cardiac arrhythmias as a side effect. This technology will increase the speed and reliability with which pharmaceutical companies can navigate the FDA approval process for all new drugs.
Location: United States, New York, North Tonawanda